SEC Form 4 · accession 0001055726-18-000008
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jong Joseph Kim
Officer — Chief Executive Officer · Director
Period of report
Mar 9, 2018
Accepted (ET)
Mar 13, 2018 · 6:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 9, 2018 | M | 57,333 | — | A | 2,232,155 | D | |
| Common Stock | Mar 9, 2018 | F | 15,944 | $4.51 | D | 2,216,211 | D | |
| Common StockF3 | Mar 10, 2018 | M | 105,700 | — | A | 2,321,911 | D | |
| Common Stock | Mar 10, 2018 | F | 30,104 | $4.51 | D | 2,291,807 | D | |
| Common Stock | holding | — | — | — | 1,750,000 | I | By Family Limited Partnership | |
| Common Stock | holding | — | — | — | 33,563 | I | By Daughter: EK | |
| Common Stock | holding | — | — | — | 33,775 | I | By Son: JK1 | |
| Common Stock | holding | — | — | — | 5,975 | I | By Spouse | |
| Common Stock | holding | — | — | — | 33,533 | I | By Son: JK2 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | — | Mar 9, 2018 | M | 57,334 | D | — | — | Common Stock | 57,333 | 57,333 | D |
| Restricted Stock UnitF3 | — | Mar 10, 2018 | M | 105,700 | D | — | — | Common Stock | 105,700 | 211,400 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 172,000 restricted stock units is as follows: 57,334 shares vested on March 9, 2017; 57,333 shares vested on March 9, 2018; 57,333 shares will vest on March 9, 2019. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
- F2The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
- F3Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares will vest on March 10, 2019; 105,700 shares will vest on March 10, 2020. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
- F4The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein.